Importance and Considerations of Antibody Engineering in Antibody-Drug Conjugates Development from a Clinical Pharmacologist’s Perspective

por Lucas, Andrew T., Moody, Amber, Schorzman, Allison N., Zamboni, William C.
Publicado 2021

Pharmacologic Considerations in the Disposition of Antibodies and Antibody-Drug Conjugates in Preclinical Models and in Patients

por Lucas, Andrew T., Robinson, Ryan, Schorzman, Allison N., Piscitelli, Joseph A., Razo, Juan F., Zamboni, William C.
Publicado 2019

Factors Affecting the Pharmacology of Antibody–Drug Conjugates

por Lucas, Andrew T., Price, Lauren S. L., Schorzman, Allison N., Storrie, Mallory, Piscitelli, Joseph A., Razo, Juan, Zamboni, William C.
Publicado 2018

2′-(2-bromohexadecanoyl)-paclitaxel conjugate nanoparticles for the treatment of non-small cell lung cancer in an orthotopic xenograft mouse model

por Peng, Lei, Schorzman, Allison N, Ma, Ping, Madden, Andrew J, Zamboni, William C, Benhabbour, Soumya Rahima, Mumper, Russell J
Publicado 2014